News, musings and commentary on pharmaceutical law issues, technology, and litigation.
No advice, though.
Lawyers for consumers and injured people.(No advice on this blog, though) TOLL FREE 855-525-3955
Wednesday, October 17, 2012
Tennessee: Tainted Steroid Recall: 74 facilities in TN may have the recalled products
The Tennessee Department of Health has now confirmed that 74 healthcare facilities in Tennessee have received suspect material from New England Compounding Center that may pose a risk to some patients. The Food and Drug Administration has characterized the notification effort as recommended “out of an abundance of caution.”
How those facilities were identified: The evening of Monday, Oct. 15, the FDA provided TDH a list of more than 131,000 shipping invoices for NECC materials that went to medical facilities across the U.S. TDH staff members began work immediately to identify which NECC invoices were for materials going to Tennessee. On Oct. 16, TDH staff members were able to confirm where the majority of shipments had gone and today continue combing the invoices for additional data.
The process to notify patients: Also on the evening of Oct. 15, TDH asked for and received cooperative assistance from the Tennessee Hospital Association, the Tennessee Medical Association, the Tennessee Pharmacy Association, AMSURG and other healthcare organizations. Through a cooperative effort, TDH and its partners began contacting healthcare facilities today, providing information to help each facility with an action plan for contacting their patients. The facilities are being urged to identify which patients received potentially unsafe NECC products during heart or eye surgeries and to then contact their patients to provide information about the risk for infection. TDH anticipates some patients will begin receiving contacts as early as this week.
TDH and its partners are working with healthcare providers on the important patient identification and contact efforts. To allow time for these facilities to put their notification plans in place, TDH and its partners are providing assistance with necessary processes at all facilities. TDH estimates this work will occur very rapidly. The department respects and appreciates care providers’ desires to be the first to contact their patients about the potential risk as an important part of their clinician-patient relationship.